@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://purl.org/spar/pro/> .
@prefix ns2: <http://purl.org/spar/datacite/> .
@prefix ns3: <http://prismstandard.org/namespaces/basic/2.0/> .
@prefix ns4: <http://purl.org/vocab/frbr/core#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<> dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/legalcode> .

<https://w3id.org/oc/meta/br/0650475264> a <http://purl.org/spar/fabio/Expression>,
        <http://purl.org/spar/fabio/JournalArticle> ;
    rdfs:label "br 0650475264" ;
    ns3:publicationDate "2004-12-03"^^xsd:date ;
    dcterms:title "Characterization Of The Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3â²-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects On Anandamide And Oleoylethanolamide Deactivation" ;
    ns2:hasIdentifier <https://w3id.org/oc/meta/id/061303605431>,
        <https://w3id.org/oc/meta/id/0650542521>,
        <https://w3id.org/oc/meta/id/06630638466> ;
    ns1:isDocumentContextFor <https://w3id.org/oc/meta/ar/06501886307>,
        <https://w3id.org/oc/meta/ar/06501886308>,
        <https://w3id.org/oc/meta/ar/06501886309>,
        <https://w3id.org/oc/meta/ar/06501886310>,
        <https://w3id.org/oc/meta/ar/06501886311>,
        <https://w3id.org/oc/meta/ar/06501886312>,
        <https://w3id.org/oc/meta/ar/06501886313>,
        <https://w3id.org/oc/meta/ar/06501886314> ;
    ns4:embodiment <https://w3id.org/oc/meta/re/0650325709> ;
    ns4:partOf <https://w3id.org/oc/meta/br/0650475470> .

